CDH1 and prostate carcinoma: One of the early evidences of the CDH1 CGI hypermethylation was obtained in invasive E-cadherin-negative variants of breast and prostate cancer cell lines [78] and subsequently confirmed in other tumors, including oral [79] and breast [80] cancer.